As of January 23, 2025, Lyra Therapeutics (LYRA) has a market cap of $12.607 million USD. According to our data, Lyra Therapeutics is ranked No.8783 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $12.61 M |
-6.50%
|
Dec 31, 2024 | $13.48 M |
-96.07%
|
Dec 29, 2023 | $0.34 B |
66.88%
|
Dec 30, 2022 | $0.21 B |
-27.98%
|
Dec 31, 2021 | $0.29 B |
-61.75%
|
Dec 31, 2020 | $0.75 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
OptiNose
OPTN
|
$67.27 M |
0.000 M
|
USA
|
Sensus Healthcare
SRTS
|
$0.11 B |
-0.000 M
|
USA
|
Inspire Medical Systems
INSP
|
$5.67 B |
0.000 M
|
USA
|
Medtronic
MDT
|
$112.64 B |
0.001 M
|
Ireland
|
Smith & Nephew
SNN
|
$11.00 B |
0.000 M
|
UK
|
Boston Scientific
BSX
|
$147.84 B |
-0.008 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Abbott Laboratories
ABT
|
$204.28 B |
0.006 M
|
USA
|
Stryker Corporation
SYK
|
$148.86 B |
-0.006 M
|
USA
|
Hologic
HOLX
|
$16.07 B |
-0.000 M
|
USA
|
Market Cap | = | LYRA Stock Price | * | LYRA Shares Outstanding |
= | $0.19 | * | 65.46 M | |
= | $12.61 M |